Quick Reminder: Insider Trading Does not Maximize Shareholder Value
The NYT had an interesting piece on how top executives and corporate board members at drug companies working on coronavirus vaccines and treatments are cashing out options and selling stock just after big announcements of contracts or progress in research. While there are no explicit allegations, the implication is that many of these sales are … Continue reading Quick Reminder: Insider Trading Does not Maximize Shareholder Value
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed